EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) Stock Falls 22% in a Week: A Good Opportunity?

August 12, 2021

In recent days, there have been many stocks which have recorded considerable losses and one of those is the EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) stock. Over the course of the past week, the stock has been in the middle of a steady selloff and has actually gone down by as much as 22%. On Wednesday, the company was in the news against owing to a key announcement and it may be…


EyeGate Pharmaceuticals (NASDAQ:EYEG) Stock Sees High Volatility: What’s The Buzz?

August 2, 2021

Clinical-stage company developing and commercialising products for treating inflammatory diseases of eye and nervous system, EyeGate Pharmaceuticals (NASDAQ:EYEG) said on 28th July, 2021 that Brian M Strem, Ph.D., Co-Founder, Director and former Chief Executive Officer of Okogen, Incand Co-Founder and Managing Director of Bayon Therapeutics, will be the President, Chief Executive Officer and board member immediately.  Stream has scientific acumen, strategic expertise as well as drug development experience in ophthalmology…